Brinzolamide/timolol maleate fixed combination
Sponsors
Alcon Research
Conditions
Glaucoma
Phase 4
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
TerminatedNCT01514734
Start: 2012-03-31End: 2012-08-31Updated: 2013-10-21
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
CompletedNCT01518244
Start: 2011-12-31End: 2013-02-28Updated: 2015-08-07